West Pharmaceutical Services (WST) Interest Expenses (2009 - 2026)

West Pharmaceutical Services (WST) has 18 years of Interest Expenses data on file, last reported at $15.0 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 145.9% year-over-year to $15.0 million; the trailing twelve-month figure through Mar 2026 stood at $15.0 million (down 63.59% YoY), and the FY2025 full-year result was $107.3 million, up 230.15% from the prior year.
• Interest Expenses climbed to $15.0 million in Q1 2026, from $5.9 million in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $113.5 million in Q2 2025 to a low of $200000.0 in Q3 2025.
• A 5-year average of $12.8 million and a median of $5.0 million in 2023 frame the typical range for Interest Expenses.
• Across the five-year window, Interest Expenses sank 84.44% in 2024 and soared 656.67% in 2025, its largest moves.
• Tracing WST's Interest Expenses over 5 years: stood at $7.1 million in 2022, then plunged by 33.8% to $4.7 million in 2023, then surged by 312.77% to $19.4 million in 2024, then tumbled by 69.59% to $5.9 million in 2025, then surged by 154.24% to $15.0 million in 2026.
• Business Quant data shows WST's Interest Expenses at $15.0 million in Q1 2026, $5.9 million in Q4 2025, and $200000.0 in Q3 2025.